Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma

Fibrolamellar Hepatocellular Carcinoma

KAT-101 in Subjects With Hepatocellular Carcinoma (HCC) Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer Registry to Collect Health Information Related to Fibrolamellar Cancer Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC) A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)